Literature DB >> 1684117

Effect of neuroleptic treatment on polysomnographic measures in schizophrenia.

S F Taylor1, R Tandon, J E Shipley, A S Eiser.   

Abstract

To study the effects of neuroleptic therapy on sleep EEG variables in schizophrenia, as well as the clinical correlates of these variables, we performed polysomnographic (PSG) studies on 14 schizophrenic inpatients before and during neuroleptic therapy. Sleep continuity measures improved after 3 weeks of neuroleptic therapy, showing decreased sleep latency and improved sleep efficiency. REM latency increased with treatment, although half the patients continued to exhibit REM latencies less than 60 min. Other sleep stages and measures of REM sleep (density, activity, number of periods) did not appear to change with neuroleptic treatment. At baseline, REM latency had strong negative correlations with BPRS and SANS scores, but with 3 weeks of such treatment, this association disappeared. Further work is needed to distinguish direct medication effects from the effects of the changing clinical state on PSG measures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684117     DOI: 10.1016/0006-3223(91)90004-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.

Authors:  Sandra Giménez; Susana Clos; Sergio Romero; Eva Grasa; Adelaida Morte; Manuel J Barbanoj
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

2.  Spared and impaired sleep-dependent memory consolidation in schizophrenia.

Authors:  Bengi Baran; David Correll; Tessa C Vuper; Alexandra Morgan; Simon J Durrant; Dara S Manoach; Robert Stickgold
Journal:  Schizophr Res       Date:  2018-04-26       Impact factor: 4.939

Review 3.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

4.  Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study.

Authors:  S M Dursun; J K Patel; J G Burke; M A Reveley
Journal:  J Psychiatry Neurosci       Date:  1999-09       Impact factor: 6.186

Review 5.  Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.

Authors:  Stefan Cohrs
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Sleep-promoting properties of quetiapine in healthy subjects.

Authors:  Stefan Cohrs; Andrea Rodenbeck; Zhenghua Guan; Kathrin Pohlmann; Wolfgang Jordan; Andreas Meier; Eckart Rüther
Journal:  Psychopharmacology (Berl)       Date:  2004-03-17       Impact factor: 4.530

7.  Insomnia comorbid to severe psychiatric illness.

Authors:  Adriane M Soehner; Katherine A Kaplan; Allison G Harvey
Journal:  Sleep Med Clin       Date:  2013-09

Review 8.  The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review.

Authors:  Sarah Reeve; Bryony Sheaves; Daniel Freeman
Journal:  Clin Psychol Rev       Date:  2015-09-09

9.  Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis.

Authors:  Peta-Gaye L Thomas-Brown; Jacqueline S Martin; Clayton A Sewell; Wendel D Abel; Maxine D Gossell-Williams
Journal:  Front Pharmacol       Date:  2018-07-18       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.